P38α inhibitor 3
P38α inhibitor 3 (Comp G7) is a p38α inhibitor that blocks the effectiveness of myoblast differentiation[1].
Product Specifications
CAS Number
[260428-69-1]
UNSPSC
12352005
Target
P38 MAPK
Type
Reference compound
Related Pathways
MAPK/ERK Pathway
Applications
COVID-19-immunoregulation
Field of Research
Inflammation/Immunology
Assay Protocol
https://www.medchemexpress.com/p38α-inhibitor-3.html
Purity
99.82
Solubility
DMSO : 125 mg/mL (ultrasonic)
Smiles
O=C(N1CCC(CC1)CC2=CC=CC=C2)C3=CC=C(C=C3)F
Molecular Formula
C19H20FNO
Molecular Weight
297.37
References & Citations
[1]Yael Friedmann, et al. JX401, A p38alpha inhibitor containing a 4-benzylpiperidine motif, identified via a novel screening system in yeast. Mol Pharmacol. 2006 Oct;70 (4) :1395-405.
Shipping Conditions
Room Temperature
Storage Conditions
-20°C, 3 years; 4°C, 2 years (Powder)
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Available Sizes
More Discoveries
Explore Other Products
Browse additional items from our catalog
125027 50 µg
CLC7 (H (+) /Cl (-) Exchange Transporter 7, Chloride Channel 7 alpha Subunit, Chloride Channel Protein 7, ClC-7) discontinued
Sign In for Pricing
View Details 
